|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.05 CAD | -0.06% |
|
-1.09% | -1.84% |
| 05-17 | Tranche Update on BioSyent Inc. (TSXV:RX)'s Equity Buyback Plan announced on December 13, 2023. | CI |
| 05-17 | BioSyent Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
BioSyent Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CAD 7.73 million compared to CAD 6.48 million a year ago. Net income was CAD 1.77 million compared to CAD 1.18 million a year ago.
Basic earnings per share from continuing operations was CAD 0.152 compared to CAD 0.097 a year ago. Diluted earnings per share from continuing operations was CAD 0.149 compared to CAD 0.095 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -1.84% | 78.21M | |
| +40.73% | 739B | |
| +32.83% | 598B | |
| -6.30% | 353B | |
| +15.15% | 318B | |
| +4.05% | 285B | |
| +15.00% | 240B | |
| -5.52% | 206B | |
| +6.17% | 164B | |
| -0.45% | 162B |
BIOSYENT INC. 
